Novanta Inc. (NASDAQ:NOVT) CFO Sells $240,345.00 in Stock

Novanta Inc. (NASDAQ:NOVTGet Free Report) CFO Robert Buckley sold 1,500 shares of Novanta stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $160.23, for a total value of $240,345.00. Following the completion of the sale, the chief financial officer now directly owns 120,159 shares of the company’s stock, valued at approximately $19,253,076.57. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Robert Buckley also recently made the following trade(s):

  • On Thursday, February 1st, Robert Buckley sold 1,500 shares of Novanta stock. The shares were sold at an average price of $156.41, for a total value of $234,615.00.
  • On Tuesday, January 2nd, Robert Buckley sold 3,000 shares of Novanta stock. The shares were sold at an average price of $163.91, for a total value of $491,730.00.
  • On Monday, December 18th, Robert Buckley sold 900 shares of Novanta stock. The shares were sold at an average price of $170.08, for a total value of $153,072.00.
  • On Wednesday, December 6th, Robert Buckley sold 3,000 shares of Novanta stock. The shares were sold at an average price of $150.87, for a total value of $452,610.00.

Novanta Trading Up 2.5 %

Novanta stock opened at $167.44 on Monday. The company has a current ratio of 2.83, a quick ratio of 1.72 and a debt-to-equity ratio of 0.54. The business’s fifty day simple moving average is $159.99 and its two-hundred day simple moving average is $152.64. Novanta Inc. has a 12 month low of $111.20 and a 12 month high of $187.60. The company has a market capitalization of $6.00 billion, a price-to-earnings ratio of 79.73 and a beta of 1.33.

Analyst Upgrades and Downgrades

Separately, TheStreet upgraded Novanta from a “c+” rating to a “b-” rating in a research report on Thursday, December 28th.

View Our Latest Stock Analysis on Novanta

Institutional Investors Weigh In On Novanta

Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its holdings in Novanta by 0.9% in the second quarter. BlackRock Inc. now owns 4,265,133 shares of the technology company’s stock worth $785,211,000 after acquiring an additional 37,366 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Novanta by 0.6% during the third quarter. Vanguard Group Inc. now owns 3,766,008 shares of the technology company’s stock valued at $540,196,000 after purchasing an additional 22,294 shares in the last quarter. Conestoga Capital Advisors LLC lifted its holdings in shares of Novanta by 0.6% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,286,496 shares of the technology company’s stock valued at $216,659,000 after purchasing an additional 7,460 shares in the last quarter. State Street Corp lifted its holdings in shares of Novanta by 2.7% during the first quarter. State Street Corp now owns 1,177,700 shares of the technology company’s stock valued at $187,360,000 after purchasing an additional 30,979 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Novanta by 8.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,067,849 shares of the technology company’s stock valued at $169,885,000 after purchasing an additional 82,705 shares in the last quarter. 96.84% of the stock is owned by institutional investors.

Novanta Company Profile

(Get Free Report)

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion in the United States and internationally. The company operates through three segments: Photonics, Vision, and Precision Motion. The Photonics segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Featured Articles

Insider Buying and Selling by Quarter for Novanta (NASDAQ:NOVT)

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.